Dr. Salvagno is an orthopaedic surgeon with greater than 30 years of clinical experience. He has served as CEO of a public pharma company and as a medical advisor to several biomedical start-ups. He has extensive experience in business planning and development as well as clinical trial supervision. Dr. Salvagno served as Chief of Staff at Meritus Medical Center, Hagerstown Md. from 2017-2019 in Hagerstown, MD and currently serves as a member of the Board of Directors of the health system.
Our team at Dale Biotech recognizes the need for the best scientific minds to come together to tackle the current health crisis related to COVID-19.
We are also committed to using our expertise with Rhamnolipids to develop an oral formulation which is not only efficacious but also cost effective. Our experience with Rhamnolipids and our early research with niclosamide, has led us to a unique formulation that has the potential to not only treat early cases of COVID-19 but also could be used for prophylaxis against COVID-19 and other future viral threats.
Please join us , as an investor or as follower, and support our efforts to combat this worldwide pandemic.